APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Toxoid

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Toxoid Market Analysis and Forecast 2026-2032

Report ID 174042350226 December 2025199 pages

Choose your research edition.

Industry ResearchToxoid Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Toxoid Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Toxoid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Toxoid Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Toxoid Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Toxoid market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Toxoid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Toxoid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Toxoid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Toxoid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Toxoid include Sanofi, Merck, GSK, Zoetis and Biocompare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Toxoid, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Toxoid, also provides the sales of main regions and countries. Of the upcoming market potential for Toxoid, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Toxoid sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Toxoid market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Toxoid sales, projected growth trends, production technology, application and end-user industry.

Toxoid Segment by Company

Sanofi

Merck

GSK

Zoetis

Biocompare

Toxoid Segment by Type

Diphtheria Toxoid

Tetanic Toxoid

Others

Toxoid Segment by Application

Hospitals

Clinics

Others

Toxoid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Toxoid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Toxoid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Toxoid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Toxoid in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Toxoid manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Toxoid sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Toxoid Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Diphtheria Toxoid Major Manufacturers Table 3. Tetanic Toxoid Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Toxoid Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Manufacturers Table 7. Clinics Major Manufacturers Table 8. Others Major Manufacturers Table 9. Toxoid Industry Trends Table 10. Toxoid Industry Drivers Table 11. Toxoid Industry Opportunities and Challenges Table 12. Toxoid Industry Restraints Table 13. Global Toxoid Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Toxoid Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Toxoid Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Toxoid Revenue Market Share by Region (2021-2026) Table 17. Global Toxoid Revenue Market Share by Region (2027-2032) Table 18. Global Toxoid Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Toxoid Sales by Region (2021-2026) & (K Units) Table 20. Global Toxoid Sales by Region (2027-2032) & (K Units) Table 21. Global Toxoid Sales Market Share by Region (2021-2026) Table 22. Global Toxoid Sales Market Share by Region (2027-2032) Table 23. Global Toxoid Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Toxoid Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Toxoid Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Toxoid Sales Market Share by Manufacturers (2021-2026) Table 27. Global Toxoid Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Toxoid Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Toxoid Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Toxoid Manufacturers, Product Type & Application Table 31. Global Toxoid Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Toxoid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Toxoid Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Toxoid Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Toxoid Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Toxoid Revenue Market Share by Type (2021-2026) Table 38. Global Toxoid Revenue Market Share by Type (2027-2032) Table 39. Global Toxoid Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Toxoid Sales by Type (2021-2026) & (K Units) Table 41. Global Toxoid Sales by Type (2027-2032) & (K Units) Table 42. Global Toxoid Sales Market Share by Type (2021-2026) Table 43. Global Toxoid Sales Market Share by Type (2027-2032) Table 44. Global Toxoid Price by Type (2021-2026) & (US$/Unit) Table 45. Global Toxoid Price by Type (2027-2032) & (US$/Unit) Table 46. Global Toxoid Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Toxoid Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Toxoid Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Toxoid Revenue Market Share by Application (2021-2026) Table 50. Global Toxoid Revenue Market Share by Application (2027-2032) Table 51. Global Toxoid Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Toxoid Sales by Application (2021-2026) & (K Units) Table 53. Global Toxoid Sales by Application (2027-2032) & (K Units) Table 54. Global Toxoid Sales Market Share by Application (2021-2026) Table 55. Global Toxoid Sales Market Share by Application (2027-2032) Table 56. Global Toxoid Price by Application (2021-2026) & (US$/Unit) Table 57. Global Toxoid Price by Application (2027-2032) & (US$/Unit) Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Toxoid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Sanofi Toxoid Product Portfolio Table 62. Sanofi Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Toxoid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Merck Toxoid Product Portfolio Table 67. Merck Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK Toxoid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. GSK Toxoid Product Portfolio Table 72. GSK Recent Development Table 73. Zoetis Company Information Table 74. Zoetis Business Overview Table 75. Zoetis Toxoid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Zoetis Toxoid Product Portfolio Table 77. Zoetis Recent Development Table 78. Biocompare Company Information Table 79. Biocompare Business Overview Table 80. Biocompare Toxoid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Biocompare Toxoid Product Portfolio Table 82. Biocompare Recent Development Table 83. North America Toxoid Revenue by Type (2021-2026) & (US$ Million) Table 84. North America Toxoid Revenue by Type (2027-2032) & (US$ Million) Table 85. North America Toxoid Sales by Type (2021-2026) & (K Units) Table 86. North America Toxoid Sales by Type (2027-2032) & (K Units) Table 87. North America Toxoid Sales Price by Type (2021-2026) & (US$/Unit) Table 88. North America Toxoid Sales Price by Type (2027-2032) & (US$/Unit) Table 89. North America Toxoid Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Toxoid Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Toxoid Sales by Application (2021-2026) & (K Units) Table 92. North America Toxoid Sales by Application (2027-2032) & (K Units) Table 93. North America Toxoid Sales Price by Application (2021-2026) & (US$/Unit) Table 94. North America Toxoid Sales Price by Application (2027-2032) & (US$/Unit) Table 95. North America Toxoid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Toxoid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 97. North America Toxoid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 98. North America Toxoid Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 99. North America Toxoid Sales by Country (2021-2026) & (K Units) Table 100. North America Toxoid Sales by Country (2027-2032) & (K Units) Table 101. North America Toxoid Sales Price by Country (2021-2026) & (US$/Unit) Table 102. North America Toxoid Sales Price by Country (2027-2032) & (US$/Unit) Table 103. United States Toxoid Revenue (2021-2032) & (US$ Million) Table 104. Canada Toxoid Revenue (2021-2032) & (US$ Million) Table 105. Mexico Toxoid Revenue (2021-2032) & (US$ Million) Table 106. Europe Toxoid Revenue by Type (2021-2026) & (US$ Million) Table 107. Europe Toxoid Revenue by Type (2027-2032) & (US$ Million) Table 108. Europe Toxoid Sales by Type (2021-2026) & (K Units) Table 109. Europe Toxoid Sales by Type (2027-2032) & (K Units) Table 110. Europe Toxoid Sales Price by Type (2021-2026) & (US$/Unit) Table 111. Europe Toxoid Sales Price by Type (2027-2032) & (US$/Unit) Table 112. Europe Toxoid Revenue by Application (2021-2026) & (US$ Million) Table 113. Europe Toxoid Revenue by Application (2027-2032) & (US$ Million) Table 114. Europe Toxoid Sales by Application (2021-2026) & (K Units) Table 115. Europe Toxoid Sales by Application (2027-2032) & (K Units) Table 116. Europe Toxoid Sales Price by Application (2021-2026) & (US$/Unit) Table 117. Europe Toxoid Sales Price by Application (2027-2032) & (US$/Unit) Table 118. Europe Toxoid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Toxoid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. Europe Toxoid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. Europe Toxoid Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 122. Europe Toxoid Sales by Country (2021-2026) & (K Units) Table 123. Europe Toxoid Sales by Country (2027-2032) & (K Units) Table 124. Europe Toxoid Sales Price by Country (2021-2026) & (US$/Unit) Table 125. Europe Toxoid Sales Price by Country (2027-2032) & (US$/Unit) Table 126. Germany Toxoid Revenue (2021-2032) & (US$ Million) Table 127. France Toxoid Revenue (2021-2032) & (US$ Million) Table 128. U.K. Toxoid Revenue (2021-2032) & (US$ Million) Table 129. Italy Toxoid Revenue (2021-2032) & (US$ Million) Table 130. Russia Toxoid Revenue (2021-2032) & (US$ Million) Table 131. Spain Toxoid Revenue (2021-2032) & (US$ Million) Table 132. Netherlands Toxoid Revenue (2021-2032) & (US$ Million) Table 133. Switzerland Toxoid Revenue (2021-2032) & (US$ Million) Table 134. Sweden Toxoid Revenue (2021-2032) & (US$ Million) Table 135. Poland Toxoid Revenue (2021-2032) & (US$ Million) Table 136. China Toxoid Revenue by Type (2021-2026) & (US$ Million) Table 137. China Toxoid Revenue by Type (2027-2032) & (US$ Million) Table 138. China Toxoid Sales by Type (2021-2026) & (K Units) Table 139. China Toxoid Sales by Type (2027-2032) & (K Units) Table 140. China Toxoid Sales Price by Type (2021-2026) & (US$/Unit) Table 141. China Toxoid Sales Price by Type (2027-2032) & (US$/Unit) Table 142. China Toxoid Revenue by Application (2021-2026) & (US$ Million) Table 143. China Toxoid Revenue by Application (2027-2032) & (US$ Million) Table 144. China Toxoid Sales by Application (2021-2026) & (K Units) Table 145. China Toxoid Sales by Application (2027-2032) & (K Units) Table 146. China Toxoid Sales Price by Application (2021-2026) & (US$/Unit) Table 147. China Toxoid Sales Price by Application (2027-2032) & (US$/Unit) Table 148. Asia Toxoid Revenue by Type (2021-2026) & (US$ Million) Table 149. Asia Toxoid Revenue by Type (2027-2032) & (US$ Million) Table 150. Asia Toxoid Sales by Type (2021-2026) & (K Units) Table 151. Asia Toxoid Sales by Type (2027-2032) & (K Units) Table 152. Asia Toxoid Sales Price by Type (2021-2026) & (US$/Unit) Table 153. Asia Toxoid Sales Price by Type (2027-2032) & (US$/Unit) Table 154. Asia Toxoid Revenue by Application (2021-2026) & (US$ Million) Table 155. Asia Toxoid Revenue by Application (2027-2032) & (US$ Million) Table 156. Asia Toxoid Sales by Application (2021-2026) & (K Units) Table 157. Asia Toxoid Sales by Application (2027-2032) & (K Units) Table 158. Asia Toxoid Sales Price by Application (2021-2026) & (US$/Unit) Table 159. Asia Toxoid Sales Price by Application (2027-2032) & (US$/Unit) Table 160. Asia Toxoid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Asia Toxoid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. Asia Toxoid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. Asia Toxoid Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 164. Asia Toxoid Sales by Country (2021-2026) & (K Units) Table 165. Asia Toxoid Sales by Country (2027-2032) & (K Units) Table 166. Asia Toxoid Sales Price by Country (2021-2026) & (US$/Unit) Table 167. Asia Toxoid Sales Price by Country (2027-2032) & (US$/Unit) Table 168. Japan Toxoid Revenue (2021-2032) & (US$ Million) Table 169. South Korea Toxoid Revenue (2021-2032) & (US$ Million) Table 170. India Toxoid Revenue (2021-2032) & (US$ Million) Table 171. Australia Toxoid Revenue (2021-2032) & (US$ Million) Table 172. Taiwan Toxoid Revenue (2021-2032) & (US$ Million) Table 173. Southeast Asia Toxoid Revenue (2021-2032) & (US$ Million) Table 174. SAMEA Toxoid Revenue by Type (2021-2026) & (US$ Million) Table 175. SAMEA Toxoid Revenue by Type (2027-2032) & (US$ Million) Table 176. SAMEA Toxoid Sales by Type (2021-2026) & (K Units) Table 177. SAMEA Toxoid Sales by Type (2027-2032) & (K Units) Table 178. SAMEA Toxoid Sales Price by Type (2021-2026) & (US$/Unit) Table 179. SAMEA Toxoid Sales Price by Type (2027-2032) & (US$/Unit) Table 180. SAMEA Toxoid Revenue by Application (2021-2026) & (US$ Million) Table 181. SAMEA Toxoid Revenue by Application (2027-2032) & (US$ Million) Table 182. SAMEA Toxoid Sales by Application (2021-2026) & (K Units) Table 183. SAMEA Toxoid Sales by Application (2027-2032) & (K Units) Table 184. SAMEA Toxoid Sales Price by Application (2021-2026) & (US$/Unit) Table 185. SAMEA Toxoid Sales Price by Application (2027-2032) & (US$/Unit) Table 186. SAMEA Toxoid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. SAMEA Toxoid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. SAMEA Toxoid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. SAMEA Toxoid Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 190. SAMEA Toxoid Sales by Country (2021-2026) & (K Units) Table 191. SAMEA Toxoid Sales by Country (2027-2032) & (K Units) Table 192. SAMEA Toxoid Sales Price by Country (2021-2026) & (US$/Unit) Table 193. SAMEA Toxoid Sales Price by Country (2027-2032) & (US$/Unit) Table 194. Brazil Toxoid Revenue (2021-2032) & (US$ Million) Table 195. Argentina Toxoid Revenue (2021-2032) & (US$ Million) Table 196. Chile Toxoid Revenue (2021-2032) & (US$ Million) Table 197. Colombia Toxoid Revenue (2021-2032) & (US$ Million) Table 198. Peru Toxoid Revenue (2021-2032) & (US$ Million) Table 199. Saudi Arabia Toxoid Revenue (2021-2032) & (US$ Million) Table 200. Israel Toxoid Revenue (2021-2032) & (US$ Million) Table 201. UAE Toxoid Revenue (2021-2032) & (US$ Million) Table 202. Turkey Toxoid Revenue (2021-2032) & (US$ Million) Table 203. Iran Toxoid Revenue (2021-2032) & (US$ Million) Table 204. Egypt Toxoid Revenue (2021-2032) & (US$ Million) Table 205. Key Raw Materials Table 206. Raw Materials Key Suppliers Table 207. Toxoid Distributors List Table 208. Toxoid Customers List Table 209. Research Programs/Design for This Report Table 210. Authors List of This Report Table 211. Secondary Sources Table 212. Primary Sources List of Figures Figure 1. Toxoid Image Figure 2. Global Toxoid Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Toxoid Market Size Share 2021 VS 2025 VS 2032 Figure 4. Diphtheria Toxoid Image Figure 5. Tetanic Toxoid Image Figure 6. Others Image Figure 7. Global Toxoid Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Toxoid Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Clinics Image Figure 11. Others Image Figure 12. Global Toxoid Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Toxoid Revenue (2021-2032) & (US$ Million) Figure 14. Global Toxoid Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Toxoid Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Toxoid Revenue Market Share by Region (2021-2032) Figure 17. Global Toxoid Sales (2021-2032) & (K Units) Figure 18. Global Toxoid Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Toxoid Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Toxoid Sales YoY (2021-2032) & (K Units) Figure 21. Europe Toxoid Sales YoY (2021-2032) & (K Units) Figure 22. China Toxoid Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Toxoid Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Toxoid Sales YoY (2021-2032) & (K Units) Figure 25. Global Toxoid Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Toxoid Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Toxoid Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Toxoid Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Toxoid Revenue Market Share by Type (2021-2032) Figure 31. Global Toxoid Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Toxoid Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Toxoid Sales Market Share by Type (2021-2032) Figure 34. Global Toxoid Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Toxoid Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Toxoid Revenue Market Share by Application (2021-2032) Figure 37. Global Toxoid Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Toxoid Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Toxoid Sales Market Share by Application (2021-2032) Figure 40. North America Toxoid Revenue Share by Type (2021-2032) Figure 41. North America Toxoid Sales Share by Type (2021-2032) Figure 42. North America Toxoid Revenue Share by Application (2021-2032) Figure 43. North America Toxoid Sales Share by Application (2021-2032) Figure 44. North America Toxoid Revenue Share by Country (2021-2032) Figure 45. North America Toxoid Sales Share by Country (2021-2032) Figure 46. Europe Toxoid Revenue Share by Type (2021-2032) Figure 47. Europe Toxoid Sales Share by Type (2021-2032) Figure 48. Europe Toxoid Revenue Share by Application (2021-2032) Figure 49. Europe Toxoid Sales Share by Application (2021-2032) Figure 50. Europe Toxoid Revenue Share by Country (2021-2032) Figure 51. Europe Toxoid Sales Share by Country (2021-2032) Figure 52. China Toxoid Revenue Share by Type (2021-2032) Figure 53. China Toxoid Sales Share by Type (2021-2032) Figure 54. China Toxoid Revenue Share by Application (2021-2032) Figure 55. China Toxoid Sales Share by Application (2021-2032) Figure 56. Asia Toxoid Revenue Share by Type (2021-2032) Figure 57. Asia Toxoid Sales Share by Type (2021-2032) Figure 58. Asia Toxoid Revenue Share by Application (2021-2032) Figure 59. Asia Toxoid Sales Share by Application (2021-2032) Figure 60. Asia Toxoid Revenue Share by Country (2021-2032) Figure 61. Asia Toxoid Sales Share by Country (2021-2032) Figure 62. SAMEA Toxoid Revenue Share by Type (2021-2032) Figure 63. SAMEA Toxoid Sales Share by Type (2021-2032) Figure 64. SAMEA Toxoid Revenue Share by Application (2021-2032) Figure 65. SAMEA Toxoid Sales Share by Application (2021-2032) Figure 66. SAMEA Toxoid Revenue Share by Country (2021-2032) Figure 67. SAMEA Toxoid Sales Share by Country (2021-2032) Figure 68. Toxoid Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Toxoid Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Diphtheria Toxoid
  • Tetanic Toxoid
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Sanofi
  • Merck
  • GSK
  • Zoetis
  • Biocompare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Toxoid Market by Type
  3. 1.2.1 Global Toxoid Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Diphtheria Toxoid
  5. 1.2.3 Tetanic Toxoid
  6. 1.2.4 Others
  7. 1.3 Toxoid Market by Application
  8. 1.3.1 Global Toxoid Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Clinics
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Toxoid Market Dynamics
  1. 2.1 Toxoid Industry Trends
  2. 2.2 Toxoid Industry Drivers
  3. 2.3 Toxoid Industry Opportunities and Challenges
  4. 2.4 Toxoid Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Toxoid Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Toxoid Revenue by Region
  3. 3.2.1 Global Toxoid Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Toxoid Revenue by Region (2021-2026)
  5. 3.2.3 Global Toxoid Revenue by Region (2027-2032)
  6. 3.2.4 Global Toxoid Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Toxoid Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Toxoid Sales by Region
  9. 3.4.1 Global Toxoid Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Toxoid Sales by Region (2021-2026)
  11. 3.4.3 Global Toxoid Sales by Region (2027-2032)
  12. 3.4.4 Global Toxoid Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Toxoid Revenue by Manufacturers
  2. 4.1.1 Global Toxoid Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Toxoid Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Toxoid Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Toxoid Sales by Manufacturers
  6. 4.2.1 Global Toxoid Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Toxoid Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Toxoid Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Toxoid Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Toxoid Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Toxoid Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Toxoid Manufacturers, Product Type & Application
  13. 4.7 Global Toxoid Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Toxoid Market CR5 and HHI
  16. 4.8.2 2025 Toxoid Tier 1, Tier 2, and Tier 3
5 Toxoid Market by Type
  1. 5.1 Global Toxoid Revenue by Type
  2. 5.1.1 Global Toxoid Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Toxoid Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Toxoid Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Toxoid Sales by Type
  6. 5.2.1 Global Toxoid Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Toxoid Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Toxoid Sales Market Share by Type (2021-2032)
  9. 5.3 Global Toxoid Price by Type
6 Toxoid Market by Application
  1. 6.1 Global Toxoid Revenue by Application
  2. 6.1.1 Global Toxoid Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Toxoid Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Toxoid Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Toxoid Sales by Application
  6. 6.2.1 Global Toxoid Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Toxoid Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Toxoid Sales Market Share by Application (2021-2032)
  9. 6.3 Global Toxoid Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Toxoid Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Toxoid Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Toxoid Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Toxoid Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Toxoid Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GSK Toxoid Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Zoetis
  20. 7.4.1 Zoetis Company Information
  21. 7.4.2 Zoetis Business Overview
  22. 7.4.3 Zoetis Toxoid Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Zoetis Toxoid Product Portfolio
  24. 7.4.5 Zoetis Recent Developments
  25. 7.5 Biocompare
  26. 7.5.1 Biocompare Company Information
  27. 7.5.2 Biocompare Business Overview
  28. 7.5.3 Biocompare Toxoid Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Biocompare Toxoid Product Portfolio
  30. 7.5.5 Biocompare Recent Developments
8 North America
  1. 8.1 North America Toxoid Market Size by Type
  2. 8.1.1 North America Toxoid Revenue by Type (2021-2032)
  3. 8.1.2 North America Toxoid Sales by Type (2021-2032)
  4. 8.1.3 North America Toxoid Price by Type (2021-2032)
  5. 8.2 North America Toxoid Market Size by Application
  6. 8.2.1 North America Toxoid Revenue by Application (2021-2032)
  7. 8.2.2 North America Toxoid Sales by Application (2021-2032)
  8. 8.2.3 North America Toxoid Price by Application (2021-2032)
  9. 8.3 North America Toxoid Market Size by Country
  10. 8.3.1 North America Toxoid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Toxoid Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Toxoid Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Toxoid Market Size by Type
  2. 9.1.1 Europe Toxoid Revenue by Type (2021-2032)
  3. 9.1.2 Europe Toxoid Sales by Type (2021-2032)
  4. 9.1.3 Europe Toxoid Price by Type (2021-2032)
  5. 9.2 Europe Toxoid Market Size by Application
  6. 9.2.1 Europe Toxoid Revenue by Application (2021-2032)
  7. 9.2.2 Europe Toxoid Sales by Application (2021-2032)
  8. 9.2.3 Europe Toxoid Price by Application (2021-2032)
  9. 9.3 Europe Toxoid Market Size by Country
  10. 9.3.1 Europe Toxoid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Toxoid Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Toxoid Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Toxoid Market Size by Type
  2. 10.1.1 China Toxoid Revenue by Type (2021-2032)
  3. 10.1.2 China Toxoid Sales by Type (2021-2032)
  4. 10.1.3 China Toxoid Price by Type (2021-2032)
  5. 10.2 China Toxoid Market Size by Application
  6. 10.2.1 China Toxoid Revenue by Application (2021-2032)
  7. 10.2.2 China Toxoid Sales by Application (2021-2032)
  8. 10.2.3 China Toxoid Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Toxoid Market Size by Type
  2. 11.1.1 Asia Toxoid Revenue by Type (2021-2032)
  3. 11.1.2 Asia Toxoid Sales by Type (2021-2032)
  4. 11.1.3 Asia Toxoid Price by Type (2021-2032)
  5. 11.2 Asia Toxoid Market Size by Application
  6. 11.2.1 Asia Toxoid Revenue by Application (2021-2032)
  7. 11.2.2 Asia Toxoid Sales by Application (2021-2032)
  8. 11.2.3 Asia Toxoid Price by Application (2021-2032)
  9. 11.3 Asia Toxoid Market Size by Country
  10. 11.3.1 Asia Toxoid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Toxoid Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Toxoid Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Toxoid Market Size by Type
  2. 12.1.1 SAMEA Toxoid Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Toxoid Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Toxoid Price by Type (2021-2032)
  5. 12.2 SAMEA Toxoid Market Size by Application
  6. 12.2.1 SAMEA Toxoid Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Toxoid Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Toxoid Price by Application (2021-2032)
  9. 12.3 SAMEA Toxoid Market Size by Country
  10. 12.3.1 SAMEA Toxoid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Toxoid Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Toxoid Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Toxoid Value Chain Analysis
  2. 13.1.1 Toxoid Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Toxoid Production Mode & Process
  6. 13.2 Toxoid Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Toxoid Distributors
  9. 13.2.3 Toxoid Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst